JP2015221806A5 - - Google Patents

Download PDF

Info

Publication number
JP2015221806A5
JP2015221806A5 JP2015133015A JP2015133015A JP2015221806A5 JP 2015221806 A5 JP2015221806 A5 JP 2015221806A5 JP 2015133015 A JP2015133015 A JP 2015133015A JP 2015133015 A JP2015133015 A JP 2015133015A JP 2015221806 A5 JP2015221806 A5 JP 2015221806A5
Authority
JP
Japan
Prior art keywords
acid
dosage form
oral dosage
pharmaceutically acceptable
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015133015A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015221806A (ja
JP6258264B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015221806A publication Critical patent/JP2015221806A/ja
Publication of JP2015221806A5 publication Critical patent/JP2015221806A5/ja
Application granted granted Critical
Publication of JP6258264B2 publication Critical patent/JP6258264B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015133015A 2006-08-08 2015-07-01 ヒトの血小板レベルを増加させるための組成物および方法 Active JP6258264B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83633406P 2006-08-08 2006-08-08
US60/836,334 2006-08-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012239767A Division JP2013047257A (ja) 2006-08-08 2012-10-31 ヒトの血小板レベルを増加させるための組成物および方法

Publications (3)

Publication Number Publication Date
JP2015221806A JP2015221806A (ja) 2015-12-10
JP2015221806A5 true JP2015221806A5 (https=) 2016-06-30
JP6258264B2 JP6258264B2 (ja) 2018-01-10

Family

ID=39082656

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009523867A Pending JP2010500361A (ja) 2006-08-08 2007-08-08 ヒトの血小板レベルを増加させるための組成物および方法
JP2012239767A Withdrawn JP2013047257A (ja) 2006-08-08 2012-10-31 ヒトの血小板レベルを増加させるための組成物および方法
JP2015133015A Active JP6258264B2 (ja) 2006-08-08 2015-07-01 ヒトの血小板レベルを増加させるための組成物および方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2009523867A Pending JP2010500361A (ja) 2006-08-08 2007-08-08 ヒトの血小板レベルを増加させるための組成物および方法
JP2012239767A Withdrawn JP2013047257A (ja) 2006-08-08 2012-10-31 ヒトの血小板レベルを増加させるための組成物および方法

Country Status (8)

Country Link
US (2) US20080039475A1 (https=)
EP (2) EP2452674B1 (https=)
JP (3) JP2010500361A (https=)
AU (2) AU2007284644B2 (https=)
CA (1) CA2660283C (https=)
ES (2) ES2470333T3 (https=)
IL (4) IL196897A (https=)
WO (1) WO2008021283A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1466912T3 (da) 2002-01-18 2013-07-01 Astellas Pharma Inc 2-acylaminothiazolderivat eller salt deraf
EP2464352A1 (en) * 2009-08-14 2012-06-20 Eisai Inc. Use of e5501 for stimulating platelet production
CN112022825B (zh) * 2020-08-24 2024-03-22 瑞阳制药股份有限公司 马来酸阿伐曲泊帕片剂及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330998A (en) * 1988-03-08 1994-07-19 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
US5256675A (en) * 1989-08-07 1993-10-26 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
FR2677356B1 (fr) * 1991-06-05 1995-03-17 Sanofi Sa Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant.
US5250732A (en) * 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
GB9126677D0 (en) * 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
EP0620403B1 (de) * 1993-04-08 1996-12-04 ABB Management AG Misch- und Flammenstabilisierungseinrichtung in einer Brennkammer mit Vormischverbrennung
EP0768311B1 (en) * 1995-03-09 2003-08-06 Kyowa Hakko Kogyo Co., Ltd. Pyrrolocarbazole derivatives
EP0823423B1 (en) * 1995-04-28 2004-06-16 Banyu Pharmaceutical Co., Ltd. 1,4-disubstituted piperidine derivatives
TR199701526T1 (xx) * 1995-06-07 1998-03-21 Glaxo Group Limited Bir trombopoietin resept�r�ne ba�lanan peptitler ve bile�ikler.
US5963666A (en) * 1995-08-18 1999-10-05 International Business Machines Corporation Confusion matrix mediated word prediction
AU702751B2 (en) * 1995-10-17 1999-03-04 Daiichi Suntory Pharma Co., Ltd Therapeutics for thrombocytopenia
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
US6187797B1 (en) * 1996-12-23 2001-02-13 Dupont Pharmaceuticals Company Phenyl-isoxazoles as factor XA Inhibitors
WO2000017175A1 (en) * 1998-09-18 2000-03-30 Vertex Pharmaceuticals Incorporated INHIBITORS OF p38
JP2002529502A (ja) * 1998-11-17 2002-09-10 スミスクライン・ビーチャム・コーポレイション 血小板減少症の治療法
TWI284639B (en) * 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
GB0028383D0 (en) * 2000-11-21 2001-01-03 Novartis Ag Organic compounds
CA2437248A1 (en) * 2001-02-02 2002-08-15 Takeda Chemical Industries, Ltd. Jnk inhibitor
JPWO2002062775A1 (ja) * 2001-02-02 2004-06-10 山之内製薬株式会社 2−アシルアミノチアゾール誘導体又はその塩
DK1466912T3 (da) * 2002-01-18 2013-07-01 Astellas Pharma Inc 2-acylaminothiazolderivat eller salt deraf
BR0312023A (pt) * 2002-06-27 2005-03-22 Novo Nordisk As Composto, composto ativador da glicose cinase, método para evitar a hipoglicemia, uso de um composto, e, composição farmacêutica
WO2004029049A1 (ja) * 2002-09-30 2004-04-08 Yamanouchi Pharmaceutical Co., Ltd. 2-アシルアミノチアゾール誘導体の新規な塩
US20040235834A1 (en) * 2003-03-25 2004-11-25 Farmer Luc J. Thiazoles useful as inhibitors of protein kinases
CA2529686C (en) * 2003-07-17 2010-06-15 Astellas Pharma Inc. 2-acylaminothiazole derivative or salt thereof
WO2005014561A1 (ja) * 2003-08-12 2005-02-17 Shionogi & Co., Ltd. トロンボポエチン受容体アゴニスト作用を有する化合物
CA2628848A1 (en) * 2005-11-08 2007-05-18 Astellas Pharma Inc. Compositions and methods for treating thrombocytopenia

Similar Documents

Publication Publication Date Title
JP2017528503A5 (https=)
JP2012193216A5 (https=)
JP2018534348A5 (https=)
JP2016534063A5 (https=)
JP2017537126A5 (https=)
JP2012255026A5 (https=)
RU2017114346A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
JP2017528507A5 (https=)
JP2017537066A5 (https=)
JP2018524298A5 (https=)
CN110036005A (zh) 酰胺衍生物及其在药物中的应用
JP2019516684A5 (https=)
JP2015155440A5 (https=)
ME02150B (me) Derivati piperidinona kao inhibitori mdm2 za lečenje kancera
JP2013544850A5 (https=)
JP2015187156A5 (https=)
JP2013518107A5 (https=)
JP2015524472A5 (https=)
JP2008533007A5 (https=)
JP2012513416A5 (https=)
RU2006140964A (ru) Применение флибансерина для лечения предменструальных и иных сексуальных расстройств у женщин
JP2018531273A5 (https=)
JP2016507500A5 (https=)
JP2016512818A5 (https=)
JP2015221806A5 (https=)